Bextra Not Recalled As of Yet

Kahn Gauthier Swick is investigating claims against pharmaceutical company Pharmacia on behalf of patients who have been prescribed the painkiller Bextra (valdecoxib) and later suffered side effects such as heart attack, stroke, severe skin reaction, or other adverse effects. Bextra, a COX-2 inhibitor, was approved by the federal Food and Drug Administration (FDA) on November 16, 2001, and was marketed in March, 2002. It can be prescribed for osteoarthritis, adult rheumatoid arthritis, and primary dysmennorhea.

Bextra has not been recalled at this time.

If Bextra has injured you, please use our contact form to find out if you have a potential claim.